Summary
XERIS Pharmaceuticals, Inc. (XERIS) is a biopharmaceutical company that develops injectables for the treatment of diabetes, epilepsy and immunology. The company’s products include G-Pen and G-Pump. Its G-Pen is an auto-injectable glucagon pen in Phase 2 clinical development used as an alternative to the glucagon emergency kits. XERIS’s G-Pump is a glucagon formulation used for administration via insulin-type infusion pumps. The company uses novel formulation technologies to develop formulation of diazepam for subcutaneous injection. It has collaboration with research institute, universities and other private foundations. XERIS is headquartered in Austin, Texas, the US.
XERIS Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
XERIS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
XERIS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
XERIS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
XERIS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
XERIS Pharmaceuticals, Inc., Medical Devices Deals, 2010 to YTD 2016 9
XERIS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
XERIS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Xeris Pharmaceuticals Raises USD41 Million in Series C Financing Round 11
Xeris Pharma Raises USD7.3 Million in Series B Financing 13
Xeris Pharma Secures US$1.5 Million In Series A Financing 14
Partnerships 15
Xeris Pharma Enters Into Co-Development Agreement With Latitude Pharma 15
Licensing Agreements 17
Xeris Pharma Enters Into Licensing Agreement With University of Colorado 17
Equity Offering 19
Xeris Pharma Raises USD13 Million in Private Placement of Preferred Shares 19
XERIS Pharmaceuticals, Inc. - Key Competitors 20
Key Employees 21
Locations And Subsidiaries 22
Head Office 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23
List of Tables
XERIS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Key Facts 1
XERIS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
XERIS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
XERIS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
XERIS Pharmaceuticals, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
XERIS Pharmaceuticals, Inc., Medical Devices Deals, 2010 to YTD 2016 9
XERIS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Xeris Pharmaceuticals Raises USD41 Million in Series C Financing Round 11
Xeris Pharma Raises USD7.3 Million in Series B Financing 13
Xeris Pharma Secures US$1.5 Million In Series A Financing 14
Xeris Pharma Enters Into Co-Development Agreement With Latitude Pharma 15
Xeris Pharma Enters Into Licensing Agreement With University of Colorado 17
Xeris Pharma Raises USD13 Million in Private Placement of Preferred Shares 19
XERIS Pharmaceuticals, Inc., Key Competitors 20
XERIS Pharmaceuticals, Inc., Key Employees 21
List of Figures
XERIS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
XERIS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
XERIS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
XERIS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
XERIS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
XERIS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
XERIS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
XERIS Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
XERIS Pharmaceuticals, Inc., Medical Devices Deals, 2010 to YTD 2016 9